ãã€ãªãã¯ãããžãŒäŒæ¥ã§ãã Heron Therapeutics, Inc. ã¯ãæºããããŠããªãå»çããŒãºã«å¯Ÿå¿ããæ²»çæ³ã®éçºã«åãçµãã§ããŸããå瀟ã®è£œååè£ã¯ãç¬èªã®è¬ç©ééæè¡ã§ãã Biochronomer ãå©çšããŠããããã㯠1 åã®æäžã§æ°æ¥ããæ°é±éã«ããã£ãŠããŸããŸãªçæéäœçšåè¬å€ãæ²»çã¬ãã«ãŸã§ééããŸããå瀟ã¯ãäžç床ã®å¬åæ§ååŠçæ³ãŸãã¯ã¢ã³ãã©ãµã€ã¯ãªã³ããã³ã·ã¯ããã¹ãã¡ãã䜵çšååŠçæ³ã¬ãžã¡ã³ã«é¢é£ããæ¥æ§ããã³é
å»¶æ§ã®æªå¿ããã³ååãäºé²ããããã®åŸæŸæ§æ³šå°å€ SUSTOL (ã°ã©ãã»ããã³)ãããã³é«åºŠå¬åæ§çååŠçæ³ã«é¢é£ããæ¥æ§ããã³é
å»¶æ§ã®æªå¿ããã³ååããªãã³ã«äžç床ã®å¬åæ§çååŠçæ³ã«é¢é£ããæªå¿ããã³ååãäºé²ããããã®ãµãã¹ã¿ã³ã¹ P/ãã¥ãŒãããã³-1 åå®¹äœæ®æè¬ã§ããã¢ãã¬ãã¿ã³ãã®éèå
è£œå€ CINVANTI ãæäŸããŠããŸããå瀟ã¯ãŸããé®çå€ãšããŠç¬¬ III çžèšåºè©Šéšäžã®å±æéº»é
è¬ãããã«ã€ã³ãšäœçšéã®éã¹ããã€ãæ§æççè¬ã¡ããã·ã«ã ã®äºéäœçšåºå®çšéé
åè¬ HTX-011 ãšãè¡åŸé®çå€ãšããŠç¬¬ Ib/II çžèšåºè©Šéšäžã® HTX-034 ãéçºäžã§ããå瀟ã¯ä»¥å㯠AP Pharma, Inc. ãšããŠç¥ãããŠããŸãããã2014 幎 1 æã« Heron Therapeutics, Inc. ã«ç€Ÿåã倿ŽããŸãããHeron Therapeutics, Inc. 㯠1983 幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµã³ãã£ãšãŽã«æ¬ç€Ÿã眮ããŠããŸãã